Related Experiment Videos
Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer's Disease
Jenny U Johansson1,2, Nathaniel S Woodling1,3, Ju Shi1,4
1Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract:
The inflammatory response is a fundamental driving force in the pathogenesis of Alzheimer's disease (AD). In the setting of accumulating immunogenic Aß peptide assemblies, microglia, the innate immune cells of the brain, generate a non-resolving immune response and fail to adequately clear accumulating Aß peptides, accelerating neuronal and synaptic injury. Pathological, biomarker, and imaging studies point to a prominent role of the innate immune response in AD development, and the molecular components of this response are beginning to be unraveled. The inflammatory cyclooxygenase-PGE2 pathway is implicated in pre-clinical development of AD, both in epidemiology of normal aging populations and in transgenic mouse models of Familial AD. The cyclooxygenase-PGE2 pathway modulates the inflammatory response to accumulating Aß peptides through actions of specific E-prostanoid G-protein coupled receptors.
Insights
Alzheimer's disease pathogenesis involves inflammation, where brain immune cells called microglia fail to clear amyloid-beta peptides. The cyclooxygenase-prostaglandin E2 pathway is a key inflammatory target in Alzheimer's disease.
Area of Science:
- Neuroscience
- Immunology
- Pathology
Background:
- Alzheimer's disease (AD) pathogenesis is driven by inflammatory responses.
- Microglia, the brain's innate immune cells, exhibit a non-resolving inflammatory state in AD, failing to clear amyloid-beta (Aß) peptides.
- This impaired clearance accelerates neuronal and synaptic damage.
Purpose of the Study:
- To investigate the role of the innate immune response in Alzheimer's disease development.
- To explore the involvement of the cyclooxygenase-prostaglandin E2 (COX-PGE2) pathway in AD pathogenesis.
- To understand how the COX-PGE2 pathway modulates microglial responses to Aß peptides.
Main Methods:
- Analysis of pathological, biomarker, and imaging studies in AD.
- Examination of epidemiological data from aging populations.
- Investigation of transgenic mouse models of Familial AD.
Main Results:
- Pathological and imaging studies confirm a significant role for the innate immune response in AD.
- The cyclooxygenase-prostaglandin E2 (COX-PGE2) pathway is implicated in both human aging and familial AD models.
- This pathway influences the inflammatory reaction to accumulating Aß peptides via E-prostanoid receptors.
Conclusions:
- The innate immune response, particularly the COX-PGE2 pathway, is a critical factor in Alzheimer's disease.
- Targeting the COX-PGE2 pathway may offer therapeutic strategies for AD by modulating microglial function and Aß clearance.